Malignant melanoma of the skin: Is it something to worry about? A study on hospital discharge rates between 2018 and 2021 in Chile.
DOI:
https://doi.org/10.52611/confluencia.num1.2023.912Keywords:
Skin Neoplasms, Hospitalization, Epidemiology, MelanomaAbstract
Melanoma is a potentially fatal type of skin cancer that is steadily increasing worldwide. Currently, there are no recent studies showing the epidemiological reality of this pathology in hospitals in Chile. Objective: To calculate the hospital discharge rate and identify the year, sex, and age group with the highest hospital discharge rate for malignant skin melanoma from 2018 to 2021 in Chile. Methodology: Observational and descriptive study using data on hospital discharges in Chile from 2018 to 2021, considering the variables of sex, age group, and year. Descriptive statistics and hospital discharge rate calculations were applied. Results: Hospital discharge rate for malignant melanoma of 4.81 per 100,000 inhabitants between 2018 and 2021. The highest discharge rate corresponds to males in the 80+ age group. There was a tendency for the hospital discharge rate to increase with the age of the diagnosed patients. Discussion and conclusion: Higher hospital discharge rate in Chile compared to global incidence. During the pandemic, the hospital discharge rate decreased, probably due to the conversion of hospital beds and low screening for skin neoplasms in health checks during this period. Males were the most affected due to a lack of photoprotection and their skin morphophysiological characteristics. This study aims to contribute to national epidemiology, invite the scientific community to conduct new studies, and encourage education on risk and protective behaviours for melanoma.
Downloads
References
Carr S, Smith C, Wernberg J. Epidemiology and risk factors of melanoma. Surg Clin North Am [Internet]. 2020;100(1):1-12. Disponible en: http://dx.doi.org/10.1016/j.suc.2019.09.005
Swetter S, Geller A. Melanoma Clinical Features and diagnosis. UpToDate[Internet]. 2023 [citado el 25 de febrero de 2023]. Disponible en: https://www.uptodate.com/contents/melanoma- clinical-features-and-diagnosis
Cabrera R, Lecaros C, Uribe P, Navarrete-Dechent C, Lobos N, Gatica J, et al. Guía de práctica para el manejo de melanoma cutáneo primario de la Sociedad Chilena de Dermatología. Rev Chi Derm [Internet]. 2020 [citado el 25 de febrero de 2023];36(4):228-70. Disponible en: http://dx.doi.org/10.31879/rcderm.v36i4.404
Ayala Z, González M, Villafuerte J, Corrales Y, Pérez G, Nualla D. Caracterización histopatológica del melanoma maligno cutáneo. Provincia de Cienfuegos. 2009-2011. Medisur [Internet]. 2018 [citado el 25 de febrero de 2023];16(4):552-60. Disponible en: https://medisur.sld.cu/index.php/medisur/article/view/3 893
Castañeda P, Eljure J. El cáncer de piel, un problema actual. Rev Fac Med (UNAM) [Internet]. 2016 [citado el 25 de febrero de 2023];59(2):6-14. Disponible en: http://www.scielo.org.mx/scielo.php?script=sci_arttext &pid=S0026-17422016000200006&lng=es
Dimitriou F, Krattinger R, Ramelyte E, Barysch MJ, Micaletto S, Dummer R, et al. The world of melanoma: Epidemiologic, genetic, and anatomic differences of melanoma across the globe. Curr Oncol Rep [Internet]. 2018 [citado el 25 de febrero de 2023];20(11):87. Disponible en: http://dx.doi.org/10.1007/s11912-018- 0732-8
Raimondi S, Suppa M, Gandini S. Melanoma epidemiology and sun exposure. Acta Derm Venereol [Internet]. 2020 [citado el 25 de febrero de 2023];100(11):adv00136. Disponible en: http://dx.doi.org/10.2340/00015555-3491
Kehsler I, Elgueta G, Lin H, Capdeville F, Boetsch L, Hinrichs V. Melanoma maligno: análisis descriptivo dela situación epidemiológica en Chile. Revista Confluencia [Internet]. 2021[citado el 25 de febrero de 2023];4(2):42-46. Disponible en: https://revistas.udd.cl/index.php/confluencia/article/vie w/641Sabatini N, Molgó M, Vial G. Melanoma en Chile ¿Cuál es nuestra realidad? Rev médica Clín Condes [Internet]. 2018 [citado el 25 de febrero de 2023];29(4):468-76. Disponible en: http://dx.doi.org/10.1016/j.rmclc.2018.06.006 PerezM,AbisaadJA,RojasKD,MarchettiMA,Jaimes N. Skin cancer: Primary, secondary, and tertiary prevention. part I. J Am Acad Dermatol [Internet]. 2022 [citado el 25 de febrero de 2023];87(2):255-68. Disponible en: https://doi.org/10.1016/j.jaad.2021.12.066
Aguilera B, Cabrera T, Duarte J, García N, Hernández A, Pérez J, et al. COVID-19: evolución, efectos y políticas adoptadas en Chile y el mundo [Internet]. Santiago: Ministerio de Hacienda, Gobierno de Chile; 2022 [citado el 25 de febrero de 2023]. Disponible en: https://www.dipres.gob.cl/598/articles- 266625_doc_pdf.pdf
Vasicek BE, Szpunar SM, Manz-Dulac LA. Patient knowledge of sunscreen guidelines and frequency of physician counseling: A cross-sectional study. J Clin Aesthet Dermatol [Internet]. 2018 [citado el 25 de febrero de 2023];11(1):35-40. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/pmc5788267/ Liu-Smith F, Farhat AM, Arce A, Ziogas A, Taylor T, Wang Z, et al. Sex differences in the association of cutaneous melanoma incidence rates and geographic ultraviolet light exposure. J Am Acad Dermatol [Internet]. 2017 [citado el 25 de febrero de 2023];76(3):499-505.e3. Disponible en: http://dx.doi.org/10.1016/j.jaad.2016.08.027
Young AR, Claveau J, Rossi AB. Ultraviolet radiation and the skin: Photobiology and sunscreen photoprotection. J Am Acad Dermatol [Internet]. 2017 [citado el 25 de febrero de 2023];76(3S1):S100-9. Disponible en: http://dx.doi.org/10.1016/j.jaad.2016.09.038
Gordon LG, Leung W, Johns R, McNoe B, Lindsay D, Merollini KMD, et al. Estimated healthcare costs of melanoma and keratinocyte skin cancers in Australia and Aotearoa New Zealand in 2021. Int J Environ Res Public Health [Internet]. 2022 [citado el 25 de febrero de 2023];19(6):3178. Disponible en: http://dx.doi.org/10.3390/ijerph19063178
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Revista Confluencia
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
